SCHEMBL9097570

SCHEMBL9097570

COC(=O)CNC(=O)c1c(O)cc[nH]c1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 2/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ GAA P10253 1/20 0.41
▸ EGLN1 Q9GZT9 8/20 0.40
▸ VEGFA P15692 4/20 0.40
▸ FLT1 P17948 4/20 0.40
▸ EGLN3 Q9H6Z9 3/20 0.40
▸ MAPK1 P28482 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ ALOX5 P09917 1/20 0.36
▸ CA12 O43570 1/20 0.36
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CA9 Q16790 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2958240 0.83 EGLN1 (0.49) KDM4EEGLN1EGLN3CA1CA2
SCHEMBL17029566 0.74 DAO (0.41) KDM4ESMN1; SMN2HSD17B10GAACA12
SCHEMBL9097002 0.71 KDM4E (0.44) KDM4EMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL9096747 0.71 KDM4E (0.41) KDM4EMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL8947242 0.68 KMT2A (0.67) KDM4EMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL1232001 0.68 CA12 (0.48) KDM4EHSD17B10CA12CA1CA2
SCHEMBL8280364 0.67 GLA (0.63) KDM4EMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL21323506 0.67 GLA (0.49) KDM4EMEN1TSHRKMT2ASMN1; SMN2
SCHEMBL2826027 0.67 DAO (0.43) KDM4ETSHRHSD17B10CA12CA1
Hydrochloric Acid SCHEMBL17595029 0.67 CA12 (0.46) KDM4EHSD17B10CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0323441-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1996-04-24 — — EP disclosed
EP-0436902-B1 5-Fluorouracil derivatives OTSUKA PHARMA CO LTD (JP) 1995-06-28 — — EP disclosed
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 — — US disclosed
EP-0436902-A1 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-07-17 — — EP disclosed
US-4983609-A Anticancer agents OTSUKA PHARMACEUTICAL (JP) 1991-01-08 — — US disclosed
US-4864021-A ANTICARCINOGENIC AGENTS, ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-09-05 — — US disclosed
EP-0323441-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1989-07-05 — — EP disclosed
EP-0180897-A2 5-Fluorouracil derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-14 — — EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 — — EP disclosed
Send feedback